Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


19.02.2024

2 Acta Haematol
5 Am J Hematol
3 Ann Hematol
4 Blood
2 Bone Marrow Transplant
1 Cancer
1 Cancer Lett
1 Cancer Res
1 Eur J Haematol
2 Exp Hematol
1 Int J Hematol
1 J Biol Chem
2 Leuk Lymphoma
1 Leuk Res
1 Leukemia
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. ZHANG Q, Dong Y, Zhai Z, Tao L, et al
    Lenalidomide treatment of isolated central nervous system relapse in acute lymphoblastic leukemia after HSCT and CAR-T cell therapy.
    Acta Haematol. 2024 Feb 15. doi: 10.1159/000537719.
    PubMed         Abstract available

  2. ZHONG T, Xu D, Li W
    Prevalence, risk factors, and prognostic value of anxiety and depression in acute myeloid leukemia.
    Acta Haematol. 2024 Feb 11. doi: 10.1159/000536457.
    PubMed         Abstract available


    Am J Hematol

  3. BATALLER A, DiNardo CD, Bazinet A, Daver NG, et al
    Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups.
    Am J Hematol. 2024 Feb 15. doi: 10.1002/ajh.27236.
    PubMed         Abstract available

  4. KITTAI AS, Hang Y, Bhat SA, Clark A, et al
    Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
    Am J Hematol. 2024 Feb 15. doi: 10.1002/ajh.27241.
    PubMed         Abstract available

  5. PRATZ KW, Jonas BA, Pullarkat V, Thirman MJ, et al
    Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
    Am J Hematol. 2024 Feb 11. doi: 10.1002/ajh.27246.
    PubMed         Abstract available

  6. AUTORE F, Visentin A, Deodato M, Vitale C, et al
    Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
    Am J Hematol. 2024 Feb 11. doi: 10.1002/ajh.27247.
    PubMed        

  7. ABAZA Y, Winer ES, Murthy GSG, Shallis RM, et al
    Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
    Am J Hematol. 2024 Feb 11. doi: 10.1002/ajh.27231.
    PubMed         Abstract available


    Ann Hematol

  8. WU X, Ma X, Song T, Liu J, et al
    The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping.
    Ann Hematol. 2024;103:917-933.
    PubMed         Abstract available

  9. KENNEDY A, Patel S, Ramanathan M, Gerber J, et al
    Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and infection risk at a single center.
    Ann Hematol. 2024;103:1031-1033.
    PubMed        

  10. KRECAK I, Cubric E, Smolic J, Vrbicic B, et al
    Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking inflammatory bowel disease, successfully treated with acalabrutinib.
    Ann Hematol. 2024;103:1021-1023.
    PubMed        


    Blood

  11. SUMMERS RJ, Teachey DT, Hunger SP
    How I treat early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) in children.
    Blood. 2024 Feb 16:blood.2023023155. doi: 10.1182/blood.2023023155.
    PubMed         Abstract available

  12. COTY-FATTAL Z, Richardson AI
    A 3-year-old with chronic myeloid leukemia.
    Blood. 2024;143:651.
    PubMed        

  13. BARAJAS JM, Rasouli M, Umeda M, Hiltenbrand R, et al
    Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors.
    Blood. 2024;143:619-630.
    PubMed         Abstract available

  14. BUENO C, Torres-Ruiz R, Velasco-Hernandez T, Molina O, et al
    A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
    Blood. 2023;142:1752-1756.
    PubMed         Abstract available


    Bone Marrow Transplant

  15. SPYRIDONIDIS A, Labopin M, Gedde-Dahl T, Ganser A, et al
    Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2024;59:217-223.
    PubMed         Abstract available

  16. HIROSE A, Koh H, Nakamae M, Nakashima Y, et al
    A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma.
    Bone Marrow Transplant. 2024 Feb 14. doi: 10.1038/s41409-024-02231.
    PubMed        


    Cancer

  17. DINH A, Savoy JM, Kontoyiannis DP, Takahashi K, et al
    Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Cancer. 2024 Feb 10. doi: 10.1002/cncr.35251.
    PubMed         Abstract available


    Cancer Lett

  18. CHENG C, Liang S, Yue K, Wu N, et al
    STAT5 is essential for inducing the suppressive subset and attenuate cytotoxicity of Vdelta2(+) T cells in acute myeloid leukemia.
    Cancer Lett. 2024 Feb 13:216730. doi: 10.1016/j.canlet.2024.216730.
    PubMed         Abstract available


    Cancer Res

  19. LIU ZS, Sinha S, Bannister M, Song A, et al
    R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.
    Cancer Res. 2024;84:577-597.
    PubMed         Abstract available


    Eur J Haematol

  20. SUN Y, Zhu G, Zhong H
    Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC-MRD and treatment guidance for elderly patients.
    Eur J Haematol. 2024 Feb 11. doi: 10.1111/ejh.14187.
    PubMed         Abstract available


    Exp Hematol

  21. TANAKA T, Kudo K, Kanezaki R, Yuzawa K, et al
    Anti-leukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome.
    Exp Hematol. 2024 Feb 9:104179. doi: 10.1016/j.exphem.2024.104179.
    PubMed         Abstract available

  22. MERZ AMA, Platzbecker U
    Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms.
    Exp Hematol. 2024;130:104130.
    PubMed         Abstract available


    Int J Hematol

  23. HISADA Y
    Dysregulated hemostasis in acute promyelocytic leukemia.
    Int J Hematol. 2024 Feb 11. doi: 10.1007/s12185-024-03708.
    PubMed         Abstract available


    J Biol Chem

  24. NAMITZ KEW, Showalter SA, Cosgrove MS
    Phase separation promotes a highly active oligomeric scaffold of the MLL1 core complex for regulation of histone H3K4 methylation.
    J Biol Chem. 2023;299:105204.
    PubMed         Abstract available


    Leuk Lymphoma

  25. ZHANG F, Hu GH, Zhang LP, Xu LP, et al
    Outcomes of haploidentical hematopoietic stem cell transplantation with 'Beijing protocol' in pediatric myeloid neoplasms post cytotoxic therapy: a case series study.
    Leuk Lymphoma. 2023 Dec 3:1-6. doi: 10.1080/10428194.2023.2281276.
    PubMed        

  26. CHAI J, Choudhuri J, Wang Q, Fang Y, et al
    Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation.
    Leuk Lymphoma. 2023;64:1662-1672.
    PubMed         Abstract available


    Leuk Res

  27. GOULART H, Sastow D, Moshier E, Martin L, et al
    Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement.
    Leuk Res. 2024;137:107452.
    PubMed         Abstract available


    Leukemia

  28. DELROCCO NJ, Loh ML, Borowitz MJ, Gupta S, et al
    Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.
    Leukemia. 2024 Feb 15. doi: 10.1038/s41375-024-02166.
    PubMed         Abstract available


    PLoS One

  29. HIRASAWA I, Odagiri H, Park G, Sanghavi R, et al
    Correction: Anti-inflammatory effects of cold atmospheric plasma irradiation on the THP-1 human acute monocytic leukemia cell line.
    PLoS One. 2024;19:e0299329.
    PubMed         Abstract available

  30. KANITTHAMNIYOM C, Wannaphut C, Pattanaprichakul P, Kungwankiattichi S, et al
    Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia.
    PLoS One. 2024;19:e0297805.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.